Renewed scrutiny of grey-market retatrutide
Awaiting primary-source check
An investigative report published in June, alongside reported MHRA enforcement activity in the UK and a sharp rise in poison centre contacts in the United States, brought fresh attention to unlicensed retatrutide sold online. Retatrutide has no marketing authorisation in any country and cannot be lawfully supplied for human use.
What this is. A dated, sourced note on something that changed. Peptide Register is an independent reference: it sells nothing, carries no advertising, and takes no money from any company selling any compound it covers. This is not medical advice. If a change affects a medicine you are prescribed, speak to your doctor or pharmacist rather than acting on something you read here.